Morgan Stanley’s Having a Bumper Year in Hong Kong
This article is for subscribers only.
A record streak for share sales by health-care and biotech companies in Hong Kong is translating into a bumper year for Morgan Stanley.
The U.S. bank has a 20.3% market share of equity offerings in Hong Kong this year, the biggest since 1999, according to Bloomberg League Tables. Goldman Sachs Group Inc. is next accounting for 7.88% while China International Capital Corp. is third with 6.25%.